Insider at Medical Device Maker Buys More Than 7,500 Shares
Oliver Engert, Chief Administrative Officer of Enovis Corporation (NYSE:ENOV) , executed a direct purchase of 7,598 shares of common stock in transactions on Sept. 2, 2026, and Sept. 3, 2026, according to a recent SEC Form 4 filing . Transaction value based on SEC Form 4 weighted average purchase price ($19.74); post-transaction value based on Sept. 3, 2026 market close ($19.40). Enovis Corporation is a global medical technology enterprise with approximately 7,802 employees and TTM revenues of $2.3 billion, positioning it as a significant player in the medical devices sector focused on musculoskeletal health solutions. The company operates across multiple therapeutic areas and geographic markets, serving healthcare professionals who treat patients with complex orthopedic and musculoskeletal conditions. Despite current profitability challenges reflected in TTM net losses, Enovis maintains a substantial revenue base and market presence in the specialized medical device industry. Continue reading